GuidelineTransplantation and cellular therapy2024

Chimeric Antigen Receptor T Cell Therapy for Myeloma: Where Are We Now and What Is Needed to Move Chimeric Antigen Receptor T Cells Forward to Earlier Lines of Therapy? Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy.

Larry D Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.